Among few of its kind in the nation, the Pituitary and Neuroendocrine Program at Brigham and Women’s Hospital (BWH) provides expert, coordinated care for patients with pituitary tumors. Led by Medical Director Whitney Woodmansee, MD, and Surgical Director Edward R. Laws, MD, FACS, the Program incorporates subspecialists, including neuroendocrinologists, neurosurgeons, neurologists, neuroradiologists, neuro-ophthalmologists, neuropathologists, radiation oncologists, neuro-oncologists, psychiatrists, and others, to optimize outcomes for patients.
Specialists in the Diabetes Program at Brigham and Women’s Hospital (BWH) are delivering a wide range of specialized integrated services and tailored therapy designed to improve care for patients with diabetes, especially those with complex conditions. “With the increasing prevalence of diabetes, we are dedicated to providing referring physicians and patients with expert specialty care and personalized approaches to treatment in order to better manage this disease across the lifespan,” said Marie E. McDonnell, MD, Director of the Diabetes Program.
The Endocrine Genetics Program, within the Division of Endocrinology, Diabetes and Hypertension at Brigham and Women’s Hospital, sees approximately 120 patients a year with a range of genetic syndromes that display endocrine features. This highly specialized program provides diagnostic evaluations and management of hereditary endocrine conditions for patients and their family members. The endocrinologist and genetic counselor team employs genetic tests, such as karyotype/microarray, single gene sequencing, gene panels, whole exome and whole genome sequencing, among others.
Naomi D. Fisher, MD, Director of the Hypertension Specialty Clinic in the Division of Endocrinology, Diabetes and Hypertension, and Laura Mauri, MD, MSc, Director of Center for Clinical Biometrics in the Division of Cardiovascular Medicine, are collaborating on innovative approaches for the treatment of hypertension.
The VITamin D and OmegA-3 TriaL (VITAL) at Brigham and Women’s Hospital (BWH) is an ongoing research study in 25,875 men and women across the U.S. investigating whether taking daily dietary supplements of vitamin D3 (2,000 IU) or omega-3 fatty acids (Omacor® fish oil, 1 gram) reduces the risk for developing cancer, heart disease, and stroke in people who do not have a prior history of these illnesses. Funded by the National Institutes of Health, the trial will also assess the nutrients’ effects on diabetes, cognitive function, and other conditions.
Providing expert care for patients with pre-existing diabetes and gestational diabetes mellitus (GDM), endocrinologists and maternal-fetal medicine specialists in the Diabetes in Pregnancy Program at Brigham and Women’s Hospital (BWH) are utilizing innovative strategies to manage diabetes in pregnancy. “Many of our patients have highly complex needs with vascular and other complications from diabetes and may be on the verge of needing dialysis when they come to us,” said Chloe A. Zera, MD, MPH, a maternal-fetal medicine specialist in the Program. “In order to see these patients safely through pregnancy and improve their health and their families’ health for the long term, we deliver seamless outpatient and inpatient care and delivery and postpartum follow up.”
For over a century, a leader in patient care, medical education and research, with expertise in virtually every specialty of medicine and surgery.
About BWH
